Melanie Aylin Cedeño Zambrano

Ms. Melanie Aylin Cedeño Zambrano

Centro de Investigación Biomédica - CENBIO, Universidad UTE, Quito, Pichincha, Ecuador
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
ATAugusto Andrés Tosi
Augusto Andrés Tosi
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Linda GuamanLinda Guaman
Linda Guaman
Background: Andean plants are rich in bioactive compounds shaped by extreme environmental conditions, contributing to their antioxidant, antimicrobial, and anti-inflammatory properties. This review explores their phytochemical composition, biological activities, and therapeutic potential in modern medicine and nutrition of three plants of Andean origin. Methods: A literature review of peer-reviewed studies was conducted, focusing on key species such as quinoa (Chenopodium quinoa), amaranth (Amaranthus spp.), and lupin (Lupinus spp.), selected for this review due to their Andean origin, long-standing role in traditional diets, and growing scientific interest in their unique phytochemical profiles and therapeutic potential. This analysis covers their phytochemistry, bioactivities, and the influence of environmental factors on compound potency. Results: These Andean-origin plants contain flavonoids, terpenoids, alkaloids, and phenolic compounds that support antioxidant, antimicrobial, anti-inflammatory, and anticancer activities. High-altitude conditions enhance the biosynthesis of these bioactives, increasing their therapeutic value. Quinoa, amaranth, and lupin show strong potential for dietary and pharmaceutical applications, particularly in metabolic health and disease prevention. Additionally, preclinical studies and clinical trials have begun exploring the efficacy of these compounds in preventing and treating metabolic and chronic diseases. Conclusions: Andean plants are a valuable source of functional bioactive molecules with diverse health benefits. Future research should optimize cultivation strategies and explore novel applications in nutrition and medicine.

1 November 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
BZBelén Rebeca Cortez Zambrano
Belén Rebeca Cortez Zambrano
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Antimicrobial resistance (AMR) and biofilm-associated infections represent major therapeutic challenges because they reduce antimicrobial susceptibility, promote persistence, and limit the effectiveness of conventional treatments. Phytochemicals offer a complementary strategy due to their multitarget antimicrobial and antibiofilm activities, including membrane disruption, oxidative stress induction, quorum-sensing interference, efflux-pump inhibition, and disruption of extracellular polymeric substances. However, their clinical application is frequently restricted by poor aqueous solubility, chemical instability, rapid degradation, limited bioavailability, and insufficient accumulation at infection sites. Encapsulation provides a means to overcome these limitations through physicochemical protection, controlled release, and improved local delivery. This review examines the main delivery platforms used to formulate antibacterial phytochemicals against multidrug-resistant and biofilm-associated bacterial pathogens, with emphasis on how carrier materials and formulation parameters influence antimicrobial and antibiofilm activity. Translational applications in antimicrobial coatings, medical devices, wound and burn infections, and combination therapies are critically discussed. Current limitations related to manufacturing scalability, reproducibility, safety, regulatory classification, methodological heterogeneity, and the limited progression from in vitro studies to clinically relevant models are also discussed. Overall, encapsulation can expand the therapeutic potential of phytochemicals, but future progress will depend on demonstrating reproducible advantages over free compounds through standardized formulation, appropriate controls, relevant preclinical models, and early integration of safety and regulatory requirements.